Industry Research Reports

Home > Reports > Chemical & Material > Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published: 2025-03-14

Pages: 78 Pages

Report ld: 4668817

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Dehydroepiandrosterone (DHEA) Intermediates market size was US$ 49.3 million in 2024 and is forecast to a readjusted size of US$ 75.9 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031. 
Dehydroepiandrosterone is an endogenous steroid hormone that is mainly secreted by the adrenal glands, as well as the gonads and brain. It is the most common steroid hormone in the human peripheral circulation.

Dehydroepiandrosterone (DHEA) Intermediates Market Size(US$)

M= millions and B=billions

The North America Dehydroepiandrosterone (DHEA) Intermediates market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key manufacturers of Dehydroepiandrosterone (DHEA) Intermediates include Yicheng Goto Pharmaceuticals Co.,Ltd., Junye Pharmaceutical Co., Ltd., Zhejiang Shenzhou Pharmaceutical Co., Ltd., Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd., Jiangsu Jiaerke Pharmaceuticals Group Corp., Hubei Dan’ao Pharmaceutical Co., Ltd., Wudang Antai Pharmaceutical Co., Ltd., Shandong Saito Biotechnology Co., Ltd., NutriScience Innovations, LLC, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Dehydroepiandrosterone (DHEA) Intermediates market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Report Metric
Details
Report Title
Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Forecasted Market Size in 2031
US$ 75.9 million
CAGR(2025-2031)
7.2%
Market Size Available for Years
2020-2031
Global Dehydroepiandrosterone (DHEA) Intermediates Companies Covered
Yicheng Goto Pharmaceuticals Co.,Ltd., Junye Pharmaceutical Co., Ltd., Zhejiang Shenzhou Pharmaceutical Co., Ltd., Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd., Jiangsu Jiaerke Pharmaceuticals Group Corp., Hubei Dan’ao Pharmaceutical Co., Ltd., Wudang Antai Pharmaceutical Co., Ltd., Shandong Saito Biotechnology Co., Ltd., NutriScience Innovations, LLC
Global Dehydroepiandrosterone (DHEA) Intermediates Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dehydroepiandrosterone (DHEA) Intermediates Market, Segment by Type
≥ 99％

Others
Global Dehydroepiandrosterone (DHEA) Intermediates Market, Segment by Application
Medicine

Dietary Supplements

Skin Care Products

Reagents

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Dehydroepiandrosterone (DHEA) Intermediates market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Others in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Dietary Supplements in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.  
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?  
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Dehydroepiandrosterone (DHEA) Intermediates value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Table of Contents

 1 Market Overview
    1.1 Dehydroepiandrosterone (DHEA) Intermediates Product Scope
    1.2 Dehydroepiandrosterone (DHEA) Intermediates by Type
        1.2.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales by Type (2020 & 2024 & 2031)
        1.2.2 ≥ 99％
        1.2.3 Others
    1.3 Dehydroepiandrosterone (DHEA) Intermediates by Application
        1.3.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Comparison by Application (2020 & 2024 & 2031)
        1.3.2 Medicine
        1.3.3 Dietary Supplements
        1.3.4 Skin Care Products
        1.3.5 Reagents
        1.3.6 Others
    1.4 Global Dehydroepiandrosterone (DHEA) Intermediates Market Estimates and Forecasts (2020-2031)
        1.4.1 Global Dehydroepiandrosterone (DHEA) Intermediates Market Size in Value Growth Rate (2020-2031)
        1.4.2 Global Dehydroepiandrosterone (DHEA) Intermediates Market Size in Volume Growth Rate (2020-2031)
        1.4.3 Global Dehydroepiandrosterone (DHEA) Intermediates Price Trends (2020-2031)
    1.5 Assumptions and Limitations

 2 Market Size and Prospective by Region
    2.1 Global Dehydroepiandrosterone (DHEA) Intermediates Market Size by Region: 2020 VS 2024 VS 2031
    2.2 Global Dehydroepiandrosterone (DHEA) Intermediates Retrospective Market Scenario by Region (2020-2025)
        2.2.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Region (2020-2025)
        2.2.2 Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Market Share by Region (2020-2025)
    2.3 Global Dehydroepiandrosterone (DHEA) Intermediates Market Estimates and Forecasts by Region (2026-2031)
        2.3.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Estimates and Forecasts by Region (2026-2031)
        2.3.2 Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Forecast by Region (2026-2031)
    2.4 Major Region and Emerging Market Analysis
        2.4.1 North America Dehydroepiandrosterone (DHEA) Intermediates Market Size and Prospective (2020-2031)
        2.4.2 Europe Dehydroepiandrosterone (DHEA) Intermediates Market Size and Prospective (2020-2031)
        2.4.3 China Dehydroepiandrosterone (DHEA) Intermediates Market Size and Prospective (2020-2031)
        2.4.4 Japan Dehydroepiandrosterone (DHEA) Intermediates Market Size and Prospective (2020-2031)

 3 Global Market Size by Type
    3.1 Global Dehydroepiandrosterone (DHEA) Intermediates Historic Market Review by Type (2020-2025)
        3.1.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales by Type (2020-2025)
        3.1.2 Global Dehydroepiandrosterone (DHEA) Intermediates Revenue by Type (2020-2025)
        3.1.3 Global Dehydroepiandrosterone (DHEA) Intermediates Price by Type (2020-2025)
    3.2 Global Dehydroepiandrosterone (DHEA) Intermediates Market Estimates and Forecasts by Type (2026-2031)
        3.2.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Forecast by Type (2026-2031)
        3.2.2 Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Forecast by Type (2026-2031)
        3.2.3 Global Dehydroepiandrosterone (DHEA) Intermediates Price Forecast by Type (2026-2031)
    3.3 Different Types Dehydroepiandrosterone (DHEA) Intermediates Representative Players

 4 Global Market Size by Application
    4.1 Global Dehydroepiandrosterone (DHEA) Intermediates Historic Market Review by Application (2020-2025)
        4.1.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales by Application (2020-2025)
        4.1.2 Global Dehydroepiandrosterone (DHEA) Intermediates Revenue by Application (2020-2025)
        4.1.3 Global Dehydroepiandrosterone (DHEA) Intermediates Price by Application (2020-2025)
    4.2 Global Dehydroepiandrosterone (DHEA) Intermediates Market Estimates and Forecasts by Application (2026-2031)
        4.2.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales Forecast by Application (2026-2031)
        4.2.2 Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Forecast by Application (2026-2031)
        4.2.3 Global Dehydroepiandrosterone (DHEA) Intermediates Price Forecast by Application (2026-2031)
    4.3 New Sources of Growth in Dehydroepiandrosterone (DHEA) Intermediates Application

 5 Competition Landscape by Players
    5.1 Global Dehydroepiandrosterone (DHEA) Intermediates Sales by Players (2020-2025)
    5.2 Global Top Dehydroepiandrosterone (DHEA) Intermediates Players by Revenue (2020-2025)
    5.3 Global Dehydroepiandrosterone (DHEA) Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dehydroepiandrosterone (DHEA) Intermediates as of 2024)
    5.4 Global Dehydroepiandrosterone (DHEA) Intermediates Average Price by Company (2020-2025)
    5.5 Global Key Manufacturers of Dehydroepiandrosterone (DHEA) Intermediates, Manufacturing Sites & Headquarters
    5.6 Global Key Manufacturers of Dehydroepiandrosterone (DHEA) Intermediates, Product Type & Application
    5.7 Global Key Manufacturers of Dehydroepiandrosterone (DHEA) Intermediates, Date of Enter into This Industry
    5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 6 Region Analysis
    6.1 North America Market: Players, Segments, Downstream and Major Customers
        6.1.1 North America Dehydroepiandrosterone (DHEA) Intermediates Sales by Company
            6.1.1.1 North America Dehydroepiandrosterone (DHEA) Intermediates Sales by Company (2020-2025)
            6.1.1.2 North America Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (2020-2025)
        6.1.2 North America Dehydroepiandrosterone (DHEA) Intermediates Sales Breakdown by Type (2020-2025)
        6.1.3 North America Dehydroepiandrosterone (DHEA) Intermediates Sales Breakdown by Application (2020-2025)
        6.1.4 North America Dehydroepiandrosterone (DHEA) Intermediates Major Customer
        6.1.5 North America Market Trend and Opportunities
    6.2 Europe Market: Players, Segments, Downstream and Major Customers
        6.2.1 Europe Dehydroepiandrosterone (DHEA) Intermediates Sales by Company
            6.2.1.1 Europe Dehydroepiandrosterone (DHEA) Intermediates Sales by Company (2020-2025)
            6.2.1.2 Europe Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (2020-2025)
        6.2.2 Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Breakdown by Type (2020-2025)
        6.2.3 Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Breakdown by Application (2020-2025)
        6.2.4 Europe Dehydroepiandrosterone (DHEA) Intermediates Major Customer
        6.2.5 Europe Market Trend and Opportunities
    6.3 China Market: Players, Segments, Downstream and Major Customers
        6.3.1 China Dehydroepiandrosterone (DHEA) Intermediates Sales by Company
            6.3.1.1 China Dehydroepiandrosterone (DHEA) Intermediates Sales by Company (2020-2025)
            6.3.1.2 China Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (2020-2025)
        6.3.2 China Dehydroepiandrosterone (DHEA) Intermediates Sales Breakdown by Type (2020-2025)
        6.3.3 China Dehydroepiandrosterone (DHEA) Intermediates Sales Breakdown by Application (2020-2025)
        6.3.4 China Dehydroepiandrosterone (DHEA) Intermediates Major Customer
        6.3.5 China Market Trend and Opportunities
    6.4 Japan Market: Players, Segments, Downstream and Major Customers
        6.4.1 Japan Dehydroepiandrosterone (DHEA) Intermediates Sales by Company
            6.4.1.1 Japan Dehydroepiandrosterone (DHEA) Intermediates Sales by Company (2020-2025)
            6.4.1.2 Japan Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (2020-2025)
        6.4.2 Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Breakdown by Type (2020-2025)
        6.4.3 Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Breakdown by Application (2020-2025)
        6.4.4 Japan Dehydroepiandrosterone (DHEA) Intermediates Major Customer
        6.4.5 Japan Market Trend and Opportunities

 7 Company Profiles and Key Figures
    7.1 Yicheng Goto Pharmaceuticals Co.,Ltd.
        7.1.1 Yicheng Goto Pharmaceuticals Co.,Ltd. Company Information
        7.1.2 Yicheng Goto Pharmaceuticals Co.,Ltd. Business Overview
        7.1.3 Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue and Gross Margin (2020-2025)
        7.1.4 Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Intermediates Products Offered
        7.1.5 Yicheng Goto Pharmaceuticals Co.,Ltd. Recent Development
    7.2 Junye Pharmaceutical Co., Ltd.
        7.2.1 Junye Pharmaceutical Co., Ltd. Company Information
        7.2.2 Junye Pharmaceutical Co., Ltd. Business Overview
        7.2.3 Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue and Gross Margin (2020-2025)
        7.2.4 Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Products Offered
        7.2.5 Junye Pharmaceutical Co., Ltd. Recent Development
    7.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd.
        7.3.1 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Company Information
        7.3.2 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Business Overview
        7.3.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue and Gross Margin (2020-2025)
        7.3.4 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Products Offered
        7.3.5 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Recent Development
    7.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
        7.4.1 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Company Information
        7.4.2 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Business Overview
        7.4.3 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue and Gross Margin (2020-2025)
        7.4.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Products Offered
        7.4.5 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Recent Development
    7.5 Jiangsu Jiaerke Pharmaceuticals Group Corp.
        7.5.1 Jiangsu Jiaerke Pharmaceuticals Group Corp. Company Information
        7.5.2 Jiangsu Jiaerke Pharmaceuticals Group Corp. Business Overview
        7.5.3 Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue and Gross Margin (2020-2025)
        7.5.4 Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Intermediates Products Offered
        7.5.5 Jiangsu Jiaerke Pharmaceuticals Group Corp. Recent Development
    7.6 Hubei Dan’ao Pharmaceutical Co., Ltd.
        7.6.1 Hubei Dan’ao Pharmaceutical Co., Ltd. Company Information
        7.6.2 Hubei Dan’ao Pharmaceutical Co., Ltd. Business Overview
        7.6.3 Hubei Dan’ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue and Gross Margin (2020-2025)
        7.6.4 Hubei Dan’ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Products Offered
        7.6.5 Hubei Dan’ao Pharmaceutical Co., Ltd. Recent Development
    7.7 Wudang Antai Pharmaceutical Co., Ltd.
        7.7.1 Wudang Antai Pharmaceutical Co., Ltd. Company Information
        7.7.2 Wudang Antai Pharmaceutical Co., Ltd. Business Overview
        7.7.3 Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue and Gross Margin (2020-2025)
        7.7.4 Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Products Offered
        7.7.5 Wudang Antai Pharmaceutical Co., Ltd. Recent Development
    7.8 Shandong Saito Biotechnology Co., Ltd.
        7.8.1 Shandong Saito Biotechnology Co., Ltd. Company Information
        7.8.2 Shandong Saito Biotechnology Co., Ltd. Business Overview
        7.8.3 Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue and Gross Margin (2020-2025)
        7.8.4 Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Products Offered
        7.8.5 Shandong Saito Biotechnology Co., Ltd. Recent Development
    7.9 NutriScience Innovations, LLC
        7.9.1 NutriScience Innovations, LLC Company Information
        7.9.2 NutriScience Innovations, LLC Business Overview
        7.9.3 NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Intermediates Sales, Revenue and Gross Margin (2020-2025)
        7.9.4 NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Intermediates Products Offered
        7.9.5 NutriScience Innovations, LLC Recent Development

 8 Dehydroepiandrosterone (DHEA) Intermediates Manufacturing Cost Analysis
    8.1 Dehydroepiandrosterone (DHEA) Intermediates Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Key Suppliers of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Dehydroepiandrosterone (DHEA) Intermediates
    8.4 Dehydroepiandrosterone (DHEA) Intermediates Industrial Chain Analysis

 9 Marketing Channel, Distributors and Customers
    9.1 Marketing Channel
    9.2 Dehydroepiandrosterone (DHEA) Intermediates Distributors List
    9.3 Dehydroepiandrosterone (DHEA) Intermediates Customers

 10 Dehydroepiandrosterone (DHEA) Intermediates Market Dynamics
    10.1 Dehydroepiandrosterone (DHEA) Intermediates Industry Trends
    10.2 Dehydroepiandrosterone (DHEA) Intermediates Market Drivers
    10.3 Dehydroepiandrosterone (DHEA) Intermediates Market Challenges
    10.4 Dehydroepiandrosterone (DHEA) Intermediates Market Restraints

 11 Research Findings and Conclusion

 12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
            12.1.1.1 Research Programs/Design
            12.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        12.1.2 Data Source
            12.1.2.1 Secondary Sources
            12.1.2.2 Primary Sources
    12.2 Author Details
    12.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Dehydroepiandrosterone (DHEA) Intermediates Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
 Table 2. Global Dehydroepiandrosterone (DHEA) Intermediates Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
 Table 3. Global Market Dehydroepiandrosterone (DHEA) Intermediates Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Dehydroepiandrosterone (DHEA) Intermediates Sales (kg) by Region (2020-2025)
 Table 5. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Region (2020-2025)
 Table 6. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 7. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Share by Region (2020-2025)
 Table 8. Global Dehydroepiandrosterone (DHEA) Intermediates Sales (kg) Forecast by Region (2026-2031)
 Table 9. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share Forecast by Region (2026-2031)
 Table 10. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 11. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Share Forecast by Region (2026-2031)
 Table 12. Global Dehydroepiandrosterone (DHEA) Intermediates Sales by Type (kg) & (2020-2025)
 Table 13. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Share by Type (2020-2025)
 Table 14. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue by Type (US$ Million) & (2020-2025)
 Table 15. Global Dehydroepiandrosterone (DHEA) Intermediates Price by Type (US$/kg) & (2020-2025)
 Table 16. Global Dehydroepiandrosterone (DHEA) Intermediates Sales by Type (kg) & (2026-2031)
 Table 17. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue by Type (US$ Million) & (2026-2031)
 Table 18. Global Dehydroepiandrosterone (DHEA) Intermediates Price by Type (US$/kg) & (2026-2031)
 Table 19. Representative Players of Each Type
 Table 20. Global Dehydroepiandrosterone (DHEA) Intermediates Sales by Application (kg) & (2020-2025)
 Table 21. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Share by Application (2020-2025)
 Table 22. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue by Application (US$ Million) & (2020-2025)
 Table 23. Global Dehydroepiandrosterone (DHEA) Intermediates Price by Application (US$/kg) & (2020-2025)
 Table 24. Global Dehydroepiandrosterone (DHEA) Intermediates Sales by Application (kg) & (2026-2031)
 Table 25. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Market Share by Application (US$ Million) & (2026-2031)
 Table 26. Global Dehydroepiandrosterone (DHEA) Intermediates Price by Application (US$/kg) & (2026-2031)
 Table 27. New Sources of Growth in Dehydroepiandrosterone (DHEA) Intermediates Application
 Table 28. Global Dehydroepiandrosterone (DHEA) Intermediates Sales by Company (kg) & (2020-2025)
 Table 29. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Share by Company (2020-2025)
 Table 30. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (US$ Million) & (2020-2025)
 Table 31. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Share by Company (2020-2025)
 Table 32. Global Dehydroepiandrosterone (DHEA) Intermediates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dehydroepiandrosterone (DHEA) Intermediates as of 2024)
 Table 33. Global Market Dehydroepiandrosterone (DHEA) Intermediates Average Price by Company (US$/kg) & (2020-2025)
 Table 34. Global Key Manufacturers of Dehydroepiandrosterone (DHEA) Intermediates, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Dehydroepiandrosterone (DHEA) Intermediates, Product Type & Application
 Table 36. Global Key Manufacturers of Dehydroepiandrosterone (DHEA) Intermediates, Date of Enter into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Dehydroepiandrosterone (DHEA) Intermediates Sales by Company (2020-2025) & (kg)
 Table 39. North America Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Company (2020-2025)
 Table 40. North America Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (2020-2025) & (US$ Million)
 Table 41. North America Dehydroepiandrosterone (DHEA) Intermediates Revenue Market Share by Company (2020-2025)
 Table 42. North America Dehydroepiandrosterone (DHEA) Intermediates Sales by Type (2020-2025) & (kg)
 Table 43. North America Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Type (2020-2025)
 Table 44. North America Dehydroepiandrosterone (DHEA) Intermediates Sales by Application (2020-2025) & (kg)
 Table 45. North America Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Application (2020-2025)
 Table 46. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales by Company (2020-2025) & (kg)
 Table 47. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Company (2020-2025)
 Table 48. Europe Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (2020-2025) & (US$ Million)
 Table 49. Europe Dehydroepiandrosterone (DHEA) Intermediates Revenue Market Share by Company (2020-2025)
 Table 50. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales by Type (2020-2025) & (kg)
 Table 51. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Type (2020-2025)
 Table 52. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales by Application (2020-2025) & (kg)
 Table 53. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Application (2020-2025)
 Table 54. China Dehydroepiandrosterone (DHEA) Intermediates Sales by Company (2020-2025) & (kg)
 Table 55. China Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Company (2020-2025)
 Table 56. China Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (2020-2025) & (US$ Million)
 Table 57. China Dehydroepiandrosterone (DHEA) Intermediates Revenue Market Share by Company (2020-2025)
 Table 58. China Dehydroepiandrosterone (DHEA) Intermediates Sales by Type (2020-2025) & (kg)
 Table 59. China Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Type (2020-2025)
 Table 60. China Dehydroepiandrosterone (DHEA) Intermediates Sales by Application (2020-2025) & (kg)
 Table 61. China Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Application (2020-2025)
 Table 62. Japan Dehydroepiandrosterone (DHEA) Intermediates Sales by Company (2020-2025) & (kg)
 Table 63. Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Company (2020-2025)
 Table 64. Japan Dehydroepiandrosterone (DHEA) Intermediates Revenue by Company (2020-2025) & (US$ Million)
 Table 65. Japan Dehydroepiandrosterone (DHEA) Intermediates Revenue Market Share by Company (2020-2025)
 Table 66. Japan Dehydroepiandrosterone (DHEA) Intermediates Sales by Type (2020-2025) & (kg)
 Table 67. Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Type (2020-2025)
 Table 68. Japan Dehydroepiandrosterone (DHEA) Intermediates Sales by Application (2020-2025) & (kg)
 Table 69. Japan Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Application (2020-2025)
 Table 70. Yicheng Goto Pharmaceuticals Co.,Ltd. Company Information
 Table 71. Yicheng Goto Pharmaceuticals Co.,Ltd. Description and Business Overview
 Table 72. Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 73. Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product
 Table 74. Yicheng Goto Pharmaceuticals Co.,Ltd. Recent Development
 Table 75. Junye Pharmaceutical Co., Ltd. Company Information
 Table 76. Junye Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 78. Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product
 Table 79. Junye Pharmaceutical Co., Ltd. Recent Development
 Table 80. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Company Information
 Table 81. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 83. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product
 Table 84. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Recent Development
 Table 85. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Company Information
 Table 86. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 88. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product
 Table 89. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Recent Development
 Table 90. Jiangsu Jiaerke Pharmaceuticals Group Corp. Company Information
 Table 91. Jiangsu Jiaerke Pharmaceuticals Group Corp. Description and Business Overview
 Table 92. Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Intermediates Product
 Table 94. Jiangsu Jiaerke Pharmaceuticals Group Corp. Recent Development
 Table 95. Hubei Dan’ao Pharmaceutical Co., Ltd. Company Information
 Table 96. Hubei Dan’ao Pharmaceutical Co., Ltd. Description and Business Overview
 Table 97. Hubei Dan’ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 98. Hubei Dan’ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product
 Table 99. Hubei Dan’ao Pharmaceutical Co., Ltd. Recent Development
 Table 100. Wudang Antai Pharmaceutical Co., Ltd. Company Information
 Table 101. Wudang Antai Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 103. Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product
 Table 104. Wudang Antai Pharmaceutical Co., Ltd. Recent Development
 Table 105. Shandong Saito Biotechnology Co., Ltd. Company Information
 Table 106. Shandong Saito Biotechnology Co., Ltd. Description and Business Overview
 Table 107. Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 108. Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Intermediates Product
 Table 109. Shandong Saito Biotechnology Co., Ltd. Recent Development
 Table 110. NutriScience Innovations, LLC Company Information
 Table 111. NutriScience Innovations, LLC Description and Business Overview
 Table 112. NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Intermediates Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 113. NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Intermediates Product
 Table 114. NutriScience Innovations, LLC Recent Development
 Table 115. Production Base and Market Concentration Rate of Raw Material
 Table 116. Key Suppliers of Raw Materials
 Table 117. Dehydroepiandrosterone (DHEA) Intermediates Distributors List
 Table 118. Dehydroepiandrosterone (DHEA) Intermediates Customers List
 Table 119. Dehydroepiandrosterone (DHEA) Intermediates Market Trends
 Table 120. Dehydroepiandrosterone (DHEA) Intermediates Market Drivers
 Table 121. Dehydroepiandrosterone (DHEA) Intermediates Market Challenges
 Table 122. Dehydroepiandrosterone (DHEA) Intermediates Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources


List of Figures
 Figure 1. Dehydroepiandrosterone (DHEA) Intermediates Product Picture
 Figure 2. Global Dehydroepiandrosterone (DHEA) Intermediates Sales (US$ Million) by Type (2020 & 2024 & 2031)
 Figure 3. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Type in 2024 & 2031
 Figure 4. ≥ 99％ Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Dehydroepiandrosterone (DHEA) Intermediates Sales (US$ Million) by Application (2020 & 2024 & 2031)
 Figure 7. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Market Share by Application in 2024 & 2031
 Figure 8. Medicine Examples
 Figure 9. Dietary Supplements Examples
 Figure 10. Skin Care Products Examples
 Figure 11. Reagents Examples
 Figure 12. Others Examples
 Figure 13. Global Dehydroepiandrosterone (DHEA) Intermediates Sales, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Growth Rate (2020-2031) & (US$ Million)
 Figure 15. Global Dehydroepiandrosterone (DHEA) Intermediates Sales (kg) Growth Rate (2020-2031)
 Figure 16. Global Dehydroepiandrosterone (DHEA) Intermediates Price Trends Growth Rate (2020-2031) & (US$/kg)
 Figure 17. Dehydroepiandrosterone (DHEA) Intermediates Report Years Considered
 Figure 18. Global Market Dehydroepiandrosterone (DHEA) Intermediates Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Figure 19. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Market Share by Region: 2020 VS 2024
 Figure 20. North America Dehydroepiandrosterone (DHEA) Intermediates Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 21. North America Dehydroepiandrosterone (DHEA) Intermediates Sales (kg) Growth Rate (2020-2031)
 Figure 22. Europe Dehydroepiandrosterone (DHEA) Intermediates Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 23. Europe Dehydroepiandrosterone (DHEA) Intermediates Sales (kg) Growth Rate (2020-2031)
 Figure 24. China Dehydroepiandrosterone (DHEA) Intermediates Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 25. China Dehydroepiandrosterone (DHEA) Intermediates Sales (kg) Growth Rate (2020-2031)
 Figure 26. Japan Dehydroepiandrosterone (DHEA) Intermediates Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 27. Japan Dehydroepiandrosterone (DHEA) Intermediates Sales (kg) Growth Rate (2020-2031)
 Figure 28. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Share by Type (2020-2025)
 Figure 29. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Share by Type (2026-2031)
 Figure 30. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Share by Type (2026-2031)
 Figure 31. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Share by Application (2020-2025)
 Figure 32. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Growth Rate by Application in 2020 & 2024
 Figure 33. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Share by Application (2026-2031)
 Figure 34. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Share by Application (2026-2031)
 Figure 35. Global Dehydroepiandrosterone (DHEA) Intermediates Sales Share by Company (2024)
 Figure 36. Global Dehydroepiandrosterone (DHEA) Intermediates Revenue Share by Company (2024)
 Figure 37. Global 5 Largest Dehydroepiandrosterone (DHEA) Intermediates Players Market Share by Revenue in Dehydroepiandrosterone (DHEA) Intermediates: 2020 & 2024
 Figure 38. Dehydroepiandrosterone (DHEA) Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 39. Manufacturing Cost Structure of Dehydroepiandrosterone (DHEA) Intermediates
 Figure 40. Manufacturing Process Analysis of Dehydroepiandrosterone (DHEA) Intermediates
 Figure 41. Dehydroepiandrosterone (DHEA) Intermediates Industrial Chain
 Figure 42. Channels of Distribution (Direct Vs Distribution)
 Figure 43. Distributors Profiles
 Figure 44. Bottom-up and Top-down Approaches for This Report
 Figure 45. Data Triangulation
 Figure 46. Key Executives Interviewed

Description

The global Dehydroepiandrosterone (DHEA) Intermediates market size was US$ 49.3 million in 2024 and is forecast to a readjusted size of US$ 75.9 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031. 
Dehydroepiandrosterone is an endogenous steroid hormone that is mainly secreted by the adrenal glands, as well as the gonads and brain. It is the most common steroid hormone in the human peripheral circulation.

The North America Dehydroepiandrosterone (DHEA) Intermediates market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key manufacturers of Dehydroepiandrosterone (DHEA) Intermediates include Yicheng Goto Pharmaceuticals Co.,Ltd., Junye Pharmaceutical Co., Ltd., Zhejiang Shenzhou Pharmaceutical Co., Ltd., Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd., Jiangsu Jiaerke Pharmaceuticals Group Corp., Hubei Dan’ao Pharmaceutical Co., Ltd., Wudang Antai Pharmaceutical Co., Ltd., Shandong Saito Biotechnology Co., Ltd., NutriScience Innovations, LLC, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Dehydroepiandrosterone (DHEA) Intermediates market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Dehydroepiandrosterone (DHEA) Intermediates market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Others in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Dietary Supplements in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.  
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?  
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Dehydroepiandrosterone (DHEA) Intermediates value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Industry: Chemical & Material

Published: 2025-03-14

Pages: 78 Pages

Report ld: 4668817

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 4250.00

Multi Users License

USD 6375.00

Corporate Users License